Liver International
Volume 45, Issue 4 e15859
LETTER TO THE EDITOR

The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21

Hsien-Hui Chung, 

Corresponding Author

Hsien-Hui Chung

Department of Pharmacy & Clinical Trial Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan

Preventive Medicine Program, Center for General Education, Chung Yuan Christian University, Taoyuan City, Taiwan

Department of Pharmacy and Master Program, College of Pharmacy and Health Care, Tajen University, Yanpu Township, Pingtung County, Taiwan

Correspondence

Hsien-Hui Chung, Ph.D. Department of Pharmacy & Clinical Trial Pharmacy, Kaohsiung Veterans General Hospital, Kaohsiung City 813414, Taiwan.

Email: [email protected]

Search for more papers by this author
First published: 02 February 2024
https://doi.org/10.1111/liv.15859
No abstract is available for this article.

DATA AVAILABILITY STATEMENT

Data sharing is not applicable to this article as no data sets were generated or analysed during the current study.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.